title: Smallpox vaccination in 2003: key information for clinicians.
authors.affiliation: Center for Civilian Biodefense Strategies and School of Medicine, Johns Hopkins University, Baltimore, MD 21287-0003, USA. jb@jhmi.edu
authors.forename: John
authors.initials: J
authors.lastname: Bartlett
authors.forename: Luciana
authors.initials: L
authors.lastname: Borio
authors.forename: Lew
authors.initials: L
authors.lastname: Radonovich
authors.forename: Julie Samia
authors.initials: JS
authors.lastname: Mair
authors.forename: Tara
authors.initials: T
authors.lastname: O'Toole
authors.forename: Michael
authors.initials: M
authors.lastname: Mair
authors.forename: Neil
authors.initials: N
authors.lastname: Halsey
authors.forename: Robert
authors.initials: R
authors.lastname: Grow
authors.forename: Thomas V
authors.initials: TV
authors.lastname: Inglesby
mesh_terms: D023482:Bioterrorism; D000075202:Contraindications; D003695:Delivery of Health Care / Q000458:organization & administration; D006801:Humans; D017589:Immunization Programs / Q000379:methods / Q000458:organization & administration; D020407:Internet; D010820:Physicians; D012899:Smallpox / Q000517:prevention & control*; D012900:Smallpox Vaccine / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology*; D014481:United States
chemical_list: D012900:Smallpox Vaccine